Tandem Diabetes Care makes the t:slim touchscreen insulin pump and the t:connect therapy management software. The FDA-cleared t:slim began shipping in late August and includes a USB port and cable for transferring device-captured data to Internet-enabled Macs or PCs. The company has raised $36.4 million toward a $50 million goal and intends to use proceeds to expand sales and marketing, build customer support systems, and fund research and development. Tandem is based in San Diego, California. It is targeting the insulin pump market — estimated at $1.5 billion in the U.S. — and the broader diabetes device market, which was projected to grow to $25.3 billion from $17.7 billion. Competitors include Medtronic, Johnson & Johnson and Roche. Tandem Diabetes Care is a San Diego, Calif.–based medical device company whose flagship product is the t:slim insulin pump. The t:slim is a credit-card-sized, slim, smartphone-like insulin pump featuring a color touchscreen; it was designed with extensive patient input through thousands of hours of interviews, focus groups and usability studies. Based on patient feedback, the company focused on making the pump stylish, discreet and easy to use so it can be worn comfortably on or under clothing. The t:slim is currently under 510(k) review with the FDA as an option for people with Type I diabetes. Financially, the company has opened a $13.7 million offering and has raised $12 million to date, spread across eight investors. Regulatory filings show the current offering is a mixture of debt and options and that the individual investors were not named. Tandem Diabetes is a San Diego-based developer of insulin pumps for diabetes management. The company designs and produces insulin-delivery devices. According to a regulatory filing, Tandem raised another $31.0M, bringing its current funding round to $52.3M. The filing did not disclose the source of the new funding. Tandem has previously raised money from Domain Associates, Second Technology Capital Investors, and TPG Ventures. Of the current funding round, $21.3M came in May.

Total raised

$67M

Funding rounds

2

Latest round

Equity

Latest activity

Sep 2012